US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

45.20

0.0000

Volume:726

Turnover:32.01K

Market Cap:33.90M

PE:- -

High:45.20

Open:45.20

Low:45.20

Close:45.20

52wk High:45.20

52wk Low:31.44

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.11

T/O Rate:0.10%

Dividend:0.14

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Natera announces new data shared at ASTRO 2026 on Signatera

Natera Presents New Signatera ctDNA Studies at Astro, Highlighting Radiation Oncology Use Cases

Forbion raises $2.6bn in a boost for Europe's biotech sector

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 26,792 Common Shares Worth $770,481

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/HELX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":45.1952,"timestamp":1791299529162,"preClose":45.1952,"halted":0,"volume":726,"delay":0,"changeRate":0,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"10-06 11:13:56 EDT","open":45.1952,"high":45.1952,"low":45.1952,"amount":32011.772100000002,"amplitude":0,"askPrice":43.7,"askSize":600,"bidPrice":43.54,"bidSize":600,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791316800000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":45.1952,"sharesOutstanding":650000,"nav":43.859,"aum":32894030.1,"dividendRate":0.003197,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.79,"preClose":45.1952,"latestTime":"16:10 EDT","volume":7,"amount":313.556,"timestamp":1791231005654,"change":-1.4052,"changeRate":-0.031092,"amplitude":0},"volumeRatio":0.107522,"impliedVol":0.1235,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.107522,"shares":750000,"dividePrice":0.1445,"high":45.1952,"amplitude":0,"preClose":45.1952,"low":45.1952,"week52Low":31.44,"pbRate":"--","week52High":45.1952,"institutionHeld":0,"latestPrice":45.1952,"eps":0,"divideRate":0.003197,"volume":726,"delay":0,"ttmEps":0,"open":45.1952,"prevYearClose":36.3062,"prevWeekClose":43.79,"prevMonthClose":44.5641,"prevQuarterClose":44.5641,"fiveDayClose":44.4008,"twentyDayClose":41.6426,"sixtyDayClose":39.7282},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673056732","title":"Natera announces new data shared at ASTRO 2026 on Signatera","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056732?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:11","pubTimestamp":1791288669,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced new data recently shared at the American Society for Radiation Oncology, ASTRO, 2026 Annual Meeting. The presentations mark...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-announces-new-data-shared-at-astro-2026-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-announces-new-data-shared-at-astro-2026-on-signatera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRA","LU0012050646.USD","LU0345770308.USD","GNOM","LU0053671581.USD","LU2065170008.USD","BK4139","LU2065171311.SGD","LU0106261612.USD","HELX","LU0963586101.USD","LU1064131342.USD","LU2324357040.USD","LU2264538146.SGD","LU2065169927.USD","LU0345770993.USD","LU2065171402.SGD","LU1988902786.USD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673056597","title":"Natera Presents New Signatera ctDNA Studies at Astro, Highlighting Radiation Oncology Use Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056597?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:03","pubTimestamp":1791288234,"startTime":"0","endTime":"0","summary":"Natera presents new Signatera ctDNA studies at ASTRO, highlighting radiation oncology use casesNatera reported new Signatera clinical data already presented at the ASTRO 2026 annual meeting, its first","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLb3spFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU0053671581.USD","LU2065170008.USD","LU1988902786.USD","LU1064131342.USD","GNOM","LU2065169927.USD","LU0963586101.USD","NTRA","LU0012050646.USD","BK4139","LU2264538146.SGD","LU0106261612.USD","HELX","LU2065171311.SGD","LU2324357040.USD","LU0345770308.USD","LU2065731478.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187292056","title":"Forbion raises $2.6bn in a boost for Europe's biotech sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1187292056","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187292056?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:00","pubTimestamp":1791288033,"startTime":"0","endTime":"0","summary":"This Dutch firm has completed a large fundraising round, even as European drugmakers and investors keep warning that the region's competitiveness is slipping.European pharmaceutical executives have...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673806850","title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 26,792 Common Shares Worth $770,481","url":"https://stock-news.laohu8.com/highlight/detail?id=2673806850","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673806850?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:13","pubTimestamp":1791245613,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 26,792 common shares worth $770,481Adaptive Biotechnologies Chief People Officer Francis Lo sold 26,792 shares on Oct. 1, 2026 at U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL73r6bl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 26,792 Common Shares Worth $770,481","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT","HELX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HELX\",params:#limit:6,delay:false,,,undefined,":[]}}